Keywords: smithkline, beecham, posts, strong, earnings, growth, ahead

SmithKline Beecham posts strong earnings growth ahead of merger with GW

Article | 20 April 2000

SmithKline Beecham has posted 12% pretax profit growth for the firstquarter of 2000 at L562 million ($888.5 million) excluding the effect of currencies, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Rezulin

Avandia

rosiglitazone

Famciclovir

Famvir

Go to drug listing